Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age

Completed

Conditions studied: Observation Safety

In brief

This is an observational post-marketing study conducted in children and adults immunized with Q/LAIV as part of routine clinical practice at Kaiser Permanente Northern California (NCKP) sites.

Key facts

Study ID

NCT01985997

Run by

MedImmune LLC

People needed

95000

Starts

2014-01-01

Expected to finish

2014-07-01

Last updated by the study team

2016-09-07

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• . Age 2 through 49 years at the time of vaccination (or index date for unvaccinated controls)
• . Membership in the KP Health Care Plan for at least 12 months prior to vaccination/index date
• . Continuous enrollment in KP Health Care Plan through 6 months following vaccination/index date.

You may not qualify if…

• NONE

Where it is running

• Research Site — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.